Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Orazi

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
The Journal of Urology|February 1, 1996
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumorsP Albers, T M Ulbright, J Albers, et al.
Blood Cancer Journal|November 11, 2014
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphomaT Zhang, J Ma, K Nie, et al.
American Journal of Clinical Pathology|April 1, 1997
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic featuresA Orazi, R A Hromas, R S Neiman, et al.
Nature Genetics|June 1, 1997
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationB H Ye, G Cattoretti, Q Shen, et al.
Leukemia|August 31, 2007
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and TreatmentG Barosi, R A Mesa, J Thiele, et al.
Journal of Clinical Pathology|June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphomaE Frei, C Visco, Z Y Xu-Monette, et al.
Gene Therapy|August 7, 2009
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiationM A Sadat, S Dirscherl, L Sastry, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Leukemia|March 23, 2012
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyC Visco, Y Li, Z Y Xu-Monette, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
The Journal of Urology|February 1, 1996
Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumorsP Albers, T M Ulbright, J Albers, et al.
Blood Cancer Journal|November 11, 2014
Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphomaT Zhang, J Ma, K Nie, et al.
American Journal of Clinical Pathology|April 1, 1997
Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic featuresA Orazi, R A Hromas, R S Neiman, et al.
Nature Genetics|June 1, 1997
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammationB H Ye, G Cattoretti, Q Shen, et al.
Leukemia|August 31, 2007
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and TreatmentG Barosi, R A Mesa, J Thiele, et al.
Journal of Clinical Pathology|June 19, 2013
Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphomaE Frei, C Visco, Z Y Xu-Monette, et al.
Gene Therapy|August 7, 2009
Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiationM A Sadat, S Dirscherl, L Sastry, et al.
Leukemia|June 18, 2014
Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromesM G Della Porta, E Travaglino, E Boveri, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Leukemia|March 23, 2012
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyC Visco, Y Li, Z Y Xu-Monette, et al.
Pageof 10